Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment.
Ezaki T, Tanaka T, Tamura R, Ohara K, Yamamoto Y, Takei J, Morimoto Y, Imai R, Kuranai Y, Akasaki Y, Toda M, Murayama Y, Miyake K, Sasaki H.
Ezaki T, et al. Among authors: sasaki h.
Brain Tumor Pathol. 2024 Apr 15. doi: 10.1007/s10014-024-00481-0. Online ahead of print.
Brain Tumor Pathol. 2024.
PMID: 38619734